These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32226334)

  • 1. Low-Dose Intralesional Recombinant Interferon-α2b in the Treatment of Mycosis Fungoides.
    Hu JK; Carlson K; Girardi M
    Yale J Biol Med; 2020 Mar; 93(1):41-44. PubMed ID: 32226334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of rIFN-gamma in the treatment of lymphoma and melanoma of the skin by systemic and intralesional administration].
    Jimbow K; Yamana K; Ishida O; Kawamura M; Ito Y; Maeda K
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):152-8. PubMed ID: 3099650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for mycosis fungoides.
    Weberschock T; Strametz R; Lorenz M; Röllig C; Bunch C; Bauer A; Schmitt J
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008946. PubMed ID: 22972128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and safety of interferon α-2a combined with phototherapy for patients with early-stage mycosis fungoides - a single-arm prospective study in 13 patients.
    Song H; Hu Z; Zhang S; Yang L; Feng J; Lu L; Liu Y; Wang T
    J Dermatolog Treat; 2024 Dec; 35(1):2350231. PubMed ID: 38754985
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferon alfa-2a maintenance after salvage autologous stem cell transplantation in atypical mycosis fungoides with central nervous system involvement.
    Doerschner M; Pekar-Lukacs A; Messerli-Odermatt O; Dommann-Scherrer C; Rütti M; Müller AM; Nair G; Kamarachev J; Kerl K; Beer M; Messerli M; Frauenknecht K; Haralambieva E; Hoetzenecker W; French LE; Guenova E
    Br J Dermatol; 2019 Dec; 181(6):1296-1302. PubMed ID: 30565216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of mycosis fungoides.
    Galper SL; Smith BD; Wilson LD
    Oncology (Williston Park); 2010 May; 24(6):491-501. PubMed ID: 20568590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safe and efficacious use of intralesional steroids for the treatment of focally resistant mycosis fungoides.
    Liu DY; Shaath T; Rajpara AN; Hanson C; Fraga G; Fischer R; Aires DJ
    J Drugs Dermatol; 2015 May; 14(5):466-71. PubMed ID: 25942664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is interferon alpha in cutaneous T-cell lymphoma a treatment of choice?
    Papa G; Tura S; Mandelli F; Vegna ML; Defazio D; Mazza P; Zinzani PL; Simoni R; DePita O; Ferranti G
    Br J Haematol; 1991 Oct; 79 Suppl 1():48-51. PubMed ID: 1931709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of cytokine genes and bcl-2 expression following immunotherapy with intralesional IFN-gamma in a patient with tumor-stage mycosis fungoides.
    Yamamoto T; Takahashi Y; Katayama I; Nishioka K
    Dermatology; 1998; 196(3):283-7. PubMed ID: 9621132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Trial of High-Dose Pegylated-Interferon-Alfa-2b Combined With Phototherapy in Advanced Stage Mycosis Fungoides.
    Walker CJ; Espinosa ML; Mehta-Shah N; Pro B; Guitart J; Kuzel T
    J Drugs Dermatol; 2021 Mar; 20(3):349-350. PubMed ID: 33683074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on skin directed therapies in mycosis fungoides.
    Lovgren ML; Scarisbrick JJ
    Chin Clin Oncol; 2019 Feb; 8(1):7. PubMed ID: 30525757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for mycosis fungoides: critical commentary on a Cochrane Systematic Review.
    Wu PA; Huang V; Bigby ME
    Br J Dermatol; 2014 May; 170(5):1015-20. PubMed ID: 24841586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of DAB389IL-2 fusion toxin in mycosis fungoides.
    Saleh MN; LeMaistre CF; Kuzel TM; Foss F; Platanias LC; Schwartz G; Ratain M; Rook A; Freytes CO; Craig F; Reuben J; Sams MW; Nichols JC
    J Am Acad Dermatol; 1998 Jul; 39(1):63-73. PubMed ID: 9674399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycosis fungoides (CTCL) associated with colorectal adenocarcinoma. A rare case of combined response to neoadjuvant therapy.
    Grimaldi L; Danzi R; Sivero L; De Capua M; Coppola A; Peltrini R; Mascolo M; Danzi M; Corcione F
    Ann Ital Chir; 2021 Mar; 10():. PubMed ID: 33798118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total skin electron beam therapy in mycosis fungoides-a shift towards lower dose?
    Chowdhary M; Song A; Zaorsky NG; Shi W
    Chin Clin Oncol; 2019 Feb; 8(1):9. PubMed ID: 30525748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case-control study of clinicopathologic features, prognosis, and therapeutic responses in patients with granulomatous mycosis fungoides.
    Li JY; Pulitzer MP; Myskowski PL; Dusza SW; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2013 Sep; 69(3):366-74. PubMed ID: 23685027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD45RA+ immunophenotype in mycosis fungoides: clinical, histological and immunophenotypical features in 22 patients.
    Fierro MT; Novelli M; Savoia P; Cambieri I; Quaglino P; Osella-Abate S; Bernengo MG
    J Cutan Pathol; 2001 Aug; 28(7):356-62. PubMed ID: 11437941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intralesional recombinant interferon beta-1a in the treatment of basal cell carcinoma: results of an open-label multicentre study.
    Kowalzick L; Rogozinski T; Wimheuer R; Pilz J; Manske U; Scholz A; Fierlbeck G; Mohr P; Ochsendorf F; Wagner G; Gaus W; Brzoska J; Jablonska S
    Eur J Dermatol; 2002; 12(6):558-61. PubMed ID: 12459527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.